Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Kenvue, Starboard
Starboard says Kenvue's skin health segment is weighing on performance
Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster growth is the reason for the stock's underperformance. Starboard Chief Investment Officer Jeffrey Smith said there is an opportunity to improve revenue growth and margins at the segment which has the Neutrogena and Aveeno brands.
Starboard Targets Another Health Company. Why Kenvue Is in Its Sights.
Tylenol, Listerine and Band-Aid maker Kenvue is the latest in the health related sector to attract an activist investor. And not just any corporate agitator, Starboard Value, which in recent days targeted pharma giant Pfizer.
Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says (update)
Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder and CEO of activist hedge fund Starboard Value said. "We are having conversations with them and there are signs that Kenvue is already going in the right direction,
Kenvue Stock Rallies
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc (NYSE:KVUE), the company behind popular consumer products like Tylenol and Listerine. What Happened: Starboard Value is pushing for changes at Kenvue,
Activist Investor Starboard Takes Aim at J&J Spinoff Kenvue on Heels of $1B Stake in Pfizer
Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its rivals, according to The Wall Street Journal.
Kenvue Stock Rallies After Activist Investor Takes Stake
Kenvue shares jumped premarket after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the Listerine maker, and wants changes made to boost the stock price. **
19h
Kenvue's Double Catalysts: Starboard Stake and Dividend Announcement
Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, ...
1d
on MSN
S&P 500 Gains and Losses Today: Housing Stocks Fall as Rate-Cut Outlook Softens
The S&P 500 fell 0.2% on Monday. The Dow tumbled 0.8%, ending a three-day winning streak for the blue-chip index. After ...
1d
Wall Street Breakfast Podcast: Perplexity AI Targets $8B Valuation In New Funding
AI search startup Perplexity aims for $8B valuation in new round. UBS sells 50% interest in Swisscard to Amex - report.
1d
Kenvue: Starboard Pushes for a Bold Turnaround
The activist hedge fund's new stake aims to revamp the Band-Aid maker's strategy and boost underperforming shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback